Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000107

Director sold 10,718 shares at $28.36 ($303,962)

  • Director acquired 23,900 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

FOUSE JACQUALYN A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-28 Exercise or conversion : show line 1 in the form 10b5-1 +23,900 117,684 D
2023-06-30 Sale : show line 2 in the form 10b5-1 −10,718 $28.36 $303,962 106,966 D
Open-market sales · 10,718 sh · avg $28.36 · $303,962

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-28 Exercise or conversion : show line 3 in the form 10b5-1 Performance share units −23,900 23,900 D
Loading xslF345X04/wk-form4_1688155663.xml…